9-(4-(tert-Butyl)pyridin-2-yl)-9H-carbazol-2-ol, 97%, 1g

4-Bromo-2-chloro-5-methylpyridine, 95.0%, 1g

4-Fluoro-7-nitro-indoline, 98%, 100mg

1-(6,7-Dichloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)ethanone, 95.0%, 1g

2-(t-Butyldimethylsiloxy)ethanol, 95%, 25g

2-Chloro-4-fluoropyridine-3-carbaldehyde, 98+%, 1g

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 12 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

6-(TERT-BUTYL)-1H-INDOLE, 95.0%, 1g

Rotilabo®-Spritzenfilter, RC, unsteril, Porengröße 0,45 µm, Ø 15 mm, 100 Stück

1H-Imidazol-3-ium Trifluoromethanesulfonate>98.0%(HPLC)(T)1g

tert-Butyl 4-amino-4-(propan-2-yl)piperidine-1-carboxylate, 98%, 100mg

6-Bromo-8-fluoronaphthalen-2-ol, 95.0%, 5g

2-Chloro-6-(trifluoromethyl)isonicotinic acid, 95.0%, 5g